Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn’s disease and ulcerative colitis

被引:0
|
作者
Diana Lacruz-Guzmán
Daniel Torres-Moreno
Francisco Pedrero
Patricia Romero-Cara
Iván García-Tercero
Javier Trujillo-Santos
Pablo Conesa-Zamora
机构
[1] Santa Lucía General University Hospital (HGUSL),Pharmacy Department
[2] HGUSL,Molecular Pathology and Pharmacogenetics Group FFIS011, Pathology Department
[3] HGUSL,Day Hospital
[4] HUGSL,Gastroenterology Department
[5] HUGSL,Internal Medicine
关键词
Tumour necrosis factor; Interleukin-1; Infliximab; Crohn’s disease; Pharmacogenetics; Ulcerative colitis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:431 / 438
页数:7
相关论文
共 50 条
  • [21] Neopterin Concentration as an Index of Disease Activity in Crohn's Disease and Ulcerative Colitis
    Husain, Nisreen
    Tokoro, Ken
    Popov, Joanna M.
    Naides, Stanley J.
    Kwasny, Mary J.
    Buchman, Alan L.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (03) : 246 - 251
  • [22] Polymorphisms of DMBT1 associate with Crohn's disease and ulcerative colitis in Chinese population
    Zhang, Qingsen
    Yang, Qinfan
    Chen, Baili
    He, Yao
    Chen, Minhu
    Zeng, Zhirong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 360 - 360
  • [23] Polymorphisms of TNFα, IL1β, and IL1RN genes in chronic obstructive pulmonary disease
    Hegab, AE
    Sakamoto, T
    Saitoh, W
    Nomura, A
    Ishii, Y
    Morishima, Y
    Iizuka, T
    Kiwamoto, T
    Matsuno, Y
    Massoud, HH
    Massoud, HM
    Hassanein, KM
    Sekizawa, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (04) : 1246 - 1252
  • [24] Early Failure of Infliximab in Patients with Ulcerative Colitis as Compared to Patients with Crohn's Disease
    Shah, Rushikesh
    Herrera, Henry
    Swaroop, Prabhakar
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S507 - S507
  • [25] Infliximab dose intensification in patients with crohn's disease and ulcerative colitis: associated costs
    Taxonera, Carlos
    Olivares, David
    Mendoza, Juanl
    Caas, Mercedes
    Diaz-Rubio, Manuel
    Rey, Enrique
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 812 - 813
  • [26] Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis
    Fasanmade, A. A.
    Adedokun, O. J.
    Olson, A.
    Strauss, R.
    Davis, H. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (05) : 297 - 308
  • [27] Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximab
    Medrano, L. M.
    Taxonera, C.
    Marquez, A.
    Barreiro-de Acosta, M.
    Gomez-Garcia, M.
    Gonzalez-Artacho, C.
    Perez-Calle, J. L.
    Bermejo, F.
    Lopez-Sanroman, A.
    Martin Arranz, M. D.
    Gisbert, J. P.
    Mendoza, J. L.
    Martin, J.
    Urcelay, E.
    Nunez, C.
    HUMAN IMMUNOLOGY, 2014, 75 (01) : 71 - 75
  • [28] Comparison of the durability of response to subcutaneous anti-TNF therapy between ulcerative colitis and Crohn's disease
    Mellotte, G.
    McShane, C.
    O'Connell, J.
    Mc Kiernan, S.
    Mac Carthy, F.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S328 - S328
  • [29] COMPARISON OF THE DURABILITY OF SUBCUTANEOUS ANTI-TNF THERAPY RESPONSE BETWEEN ULCERATIVE COLITIS AND CROHN'S DISEASE
    McShane, Catherine
    Mellotte, Gregory S.
    O'Connell, Jim W.
    Mc Kiernan, Susan
    MacCarthy, Finbar
    Kevans, David
    GASTROENTEROLOGY, 2017, 152 (05) : S587 - S588
  • [30] IL23R Gene Variants Influence Response Rate to Infliximab in Ulcerative Colitis
    Jurgens, Matthias
    Laubender, Rudiger P.
    Hartl, Franziska
    Weidinger, Maria
    Seiderer, Julia
    Wagner, Johanna
    Wetzke, Martin
    Beigel, Florian
    Pfennig, Simone
    Stallhofer, Johannes
    Tillack, Cornelia
    Goke, Burkhard
    Glas, Jurgen
    Ochsenkuhn, Thomas
    Brand, Stephan
    GASTROENTEROLOGY, 2010, 138 (05) : S677 - S677